FRIEDMAN PAUL A Insider Trading Activity

Average Profitability
32.43%
Insider Buys Quantity
16
Insider Buys Sum
$1.44M
Insider Sells Quantity
25
Insider Sells Sum
$312.66M

Insider Activity of FRIEDMAN PAUL A

According to the SEC Form 4 filings, FRIEDMAN PAUL A, being in a position of

  1. director at Madrigal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 49600 shares for $26.66M,
    over all time since 2018-06-11, has bought 8000 shares for $967,520, and sold 429382 shares for $147.39M.

Biography of FRIEDMAN PAUL A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $26,657,4622100

Comparison of Insiders on Amount of Buys and Sells

2026-01-09SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
24,800
0.1137%
$522.71$12.96M-0.78%
2025-12-10SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
24,800
0.1115%
$552.18$13.69M-7.21%
2025-08-13SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
129,172
0.5745%
$370.24$47.83M+33.99%
2025-08-12SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
43,605
0.1991%
$355.68$15.51M+39.24%
2025-08-11SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
3,203
0.0144%
$350.27$1.12M+42.99%
2025-07-18SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
1,400
0.0066%
$350.03$490,044+46.51%
2025-07-17SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
2,700
0.0124%
$350.48$946,301+40.31%
2025-07-16SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
26,176
0.1208%
$353.47$9.25M+41.83%
2024-04-08SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
26,270
0.1239%
$246.19$6.47M+12.26%
2024-04-05SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
27,613
0.1317%
$243.40$6.72M+14.57%
2024-04-04SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
18,710
0.0897%
$242.96$4.55M+15.31%
2024-04-03SaleMadrigal Pharmaceuticals, Inc.
MDGL
director
27,407
0.1377%
$245.12$6.72M+13.2%
2020-03-27PurchasePrelude Therapeutics Incorporated
PRLD
director
152,576
–
$0$0
2019-08-06SaleIncyte Corporation
INCY
director
155,868
0.0721%
$82.20$12.81M+2.18%
2019-08-02SaleIncyte Corporation
INCY
director
44,132
0.0126%
$51.37$2.27M+0.54%
2018-11-20PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
Chief Executive Officer
4,000
0.028%
$117.88$471,520-9.31%
2018-11-19PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
Chief Executive Officer
4,000
0.0278%
$124.00$496,000-14.18%
2018-06-11SaleMadrigal Pharmaceuticals, Inc.
MDGL
Chief Executive Officer
73,526
0.5365%
$287.46$21.14M-50.82%
2017-11-16SaleIncyte Corporation
INCY
director
57,014
0.0275%
$105.24$6M-34.18%
2017-03-17SaleIncyte Corporation
INCY
director
83,386
0.0428%
$148.18$12.36M-21.1%
Total: 49
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.